Walleye Capital’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,624
Closed -$303K 4968
2025
Q4
$303K Buy
66,624
+23,762
+55% +$122K ﹤0.01% 3306
2025
Q3
$263K Sell
42,862
-9,921
-19% -$62.8K ﹤0.01% 3124
2025
Q2
$342K Buy
52,783
+3,718
+8% +$20K ﹤0.01% 2952
2025
Q1
$261K Buy
49,065
+5,117
+12% +$35K ﹤0.01% 3063
2024
Q4
$369K Buy
43,948
+15,186
+53% +$117K ﹤0.01% 3245
2024
Q3
$227K Buy
+28,762
New +$259K ﹤0.01% 3911

Other funds holding TBI

Walleye Capital's TBI Position: Q1 2026 in Review

Walleye Capital sold out of Trueblue (TBI) in Q1 2026, closing a stake of 66,624 shares — an estimated $303K sold.

Walleye Capital first reported a position in TBI in Q3 2024 and held it in 6 quarters. The position peaked at $369K in Q4 2024. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Walleye Capital reported no remaining Trueblue position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 66,624 Trueblue shares in Q1 2026, an estimated $303K.
  • Walleye Capital first reported a position in Trueblue in Q3 2024 and held it in 6 quarters.
  • Walleye Capital's Trueblue position peaked at $369K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.